Dry eye syndrome is a prevalent condition that can significantly impact an individual's quality of life. At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to supporting the development of treatments that offer relief, particularly through the provision of high-quality pharmaceutical intermediates. One such critical compound is (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride (CAS 1194550-59-8), a vital component in the synthesis of Lifitegrast, an innovative treatment for this condition.

Many often ask, what is benzyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate used for? Its primary application is as a precursor in the manufacturing of Lifitegrast. Lifitegrast functions as an LFA-1 (Lymphocyte Function-Associated Antigen-1) antagonist. LFA-1 is a protein involved in immune cell adhesion and migration, playing a role in inflammatory processes that contribute to dry eye disease. By inhibiting the interaction between LFA-1 and its ligand, ICAM-1 (Intercellular Adhesion Molecule-1), Lifitegrast helps to reduce inflammation in the ocular surface, thereby alleviating the symptoms of dry eye.

The successful synthesis of lifitegrast intermediate requires precise control over chemical reactions and an unwavering commitment to purity. At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the stereochemical integrity of (S)-benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride is crucial. The molecule must possess the correct spatial arrangement of atoms to ensure it interacts effectively with its biological target when incorporated into the final Lifitegrast molecule. This is why sourcing from a reliable lifitegrast intermediate supplier china is so important. Our manufacturing processes are designed to yield intermediates with very high enantiomeric purity.

For pharmaceutical companies looking to buy lifitegrast intermediate CAS 1194550-59-8, the decision hinges on more than just the (S)-benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride price. It’s about ensuring supply chain reliability, consistent quality, and regulatory compliance. Our robust production capabilities and quality assurance systems provide our clients with the confidence they need to proceed with their drug development and manufacturing pipelines.

The development of effective treatments for conditions like dry eye syndrome is a complex scientific endeavor. It relies on the availability of specialized chemical intermediates that serve as the fundamental building blocks. NINGBO INNO PHARMCHEM CO.,LTD. is proud to play a role in this field by providing high-quality pharmaceutical ingredients that empower researchers and manufacturers to create innovative therapies. Our commitment to excellence ensures that we are a trusted partner in the journey from chemical synthesis to patient relief.